View live CONTRAFECT CORP chart to track its stock's price action. Find market predictions, CFRX financials and market news. ContraFect Corporation Common Stock (CFRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Real-time trade and investing ideas on ContraFect Corporation CFRX from the largest community of traders and investors. ContraFect Corp. advanced stock charts by MarketWatch. View CFRX historial stock data and compare to other stocks and exchanges.
CFRX Stock Price, Forecast & News (ContraFect) | MarketBeat
ContraFect Corp. is a clinical stage biotechnology company, which engages in discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious CFRX:NASDAQ CM Stock Quote - ContraFect Corp - Bloomberg ... Stock analysis for ContraFect Corp (CFRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ContraFect Corporation (CFRX) Interactive Stock Chart ... YONKERS, N.Y., March 30, 2020 -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents. Simply Wall St. Even when a business is losing money, it's possible for shareholders to make money if they buy a good Contrafect (CFRX) Stock Quote | Price Chart | Volume Chart View a financial market summary for CFRX including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to CFRX (Contrafect) stock.
Apr 03, 2020 · ContraFect Corporation (CFRX), a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the treatment of life-threatening infectious diseases, today announced the pricing of its underwritten public offering of 25,650,000 shares of its common stock at a public offering price of $0.39 per share.
Oct 25, 2019 · CFRX, Contrafect Corp - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Biotech Stocks To Watch Next Week: $CFRX $MRNS $PTLA $SESN Dec 23, 2018 · PTLA Stock. Once again, the stock chart of PTLA looks bad. Price movement has been too volatile to find a good entry and exit point. We need a consolidation at the very least to consider taking a long position. If I had to pick the strongest looking stock chart above, it would be CFRX.